Modes of action of FK506, cyclosporin A, and rapamycin.
Morris
R
R
Laboratory for Transplantation Immunology, Stanford University Medical Center, California 94305-5247.
D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism; D016572:Cyclosporine / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008213:Lymphocyte Activation / Q000187:drug effects; D008954:Models, Biological; D015394:Molecular Structure; D011090:Polyenes / Q000378:metabolism / Q000494:pharmacology*; D020123:Sirolimus; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D016559:Tacrolimus / Q000378:metabolism / Q000494:pharmacology*
D002352:Carrier Proteins; D007166:Immunosuppressive Agents; D011090:Polyenes; D016572:Cyclosporine; D020123:Sirolimus; D016559:Tacrolimus